Laboratory Scientist

CDMO

Drug Substance / API and Drug Product for Biologicals and Small Molecules

Accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada

Breakthrough technologies for highly potent , poorly soluble drugs, lyophilisation processes and specific therapeutic areas

CDMO

YDL Ventures offers integrated, end-to-end solutions for preclinical & clinical outsourcing services of both Drug Substance / API and Drug Product for Biologicals and Small Molecules. These services are provided by our partners at Eurofins CDMO (Contract Development & Manufacturing Organization). 

Eurofins CDMO are experts in breakthrough technologies for highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, paediatric dosage forms, etc.).

 

Involved in the earliest steps, our highly-qualified project management team will effectively communicate a complete drug development strategy to help meet your timelines.

The Range of Services

• Drug Substance/API development

• Solid State Research & Development

• Pre-Formulation and Formulation development

• GMP manufacturing (small & large molecules)

• Clinical packaging and logistics

• Project management and CMC RA

Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada.